文献速递帕金森病与运动障碍

进行性核上性麻痹与神经源性直立性低血压无关

Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension.
PubMed 文献 · Neurology · 2019-09-04

该回顾性尸检确诊研究比较了14例PSP、18例MSA和24例LBD患者的自主神经功能,发现PSP组无一例存在直立性低血压,而α-突触核蛋白病组为69%(p<0.0001)。PSP组肾上腺素能功能测试指标也优于其他组,提示PSP的心血管肾上腺素能系统相对保留,有助于鉴别诊断。

要点

  • PSP患者直立性低血压发生率为0%,显著低于MSA和LBD的69%。
  • PSP患者肾上腺素能功能测试指标(压力恢复时间、肾上腺素能损伤评分、血压变化幅度)均优于α-突触核蛋白病。
  • PSP患者快速眼动睡眠行为障碍发生率(33%)低于MSA(87%)和LBD(90%)。

核心结论

  • PSP的心血管肾上腺素能系统相对未受累,这有助于将PSP与α-突触核蛋白病区分开来。

研究设计与样本

  • 回顾性研究纳入尸检确诊的14例PSP、18例MSA和24例LBD患者,所有患者均接受过运动障碍专家临床评估、正式自主神经测试和尸检。

主要发现

  • PSP组直立性低血压发生率为0%,α-突触核蛋白病组为69%(p<0.0001)。
  • PSP组压力恢复时间(p=0.0008)、肾上腺素能损伤评分(p=0.001)、直立倾斜时收缩压变化幅度(p=0.0002)和舒张压变化幅度(p=0.0001)均显著区别于其他组。
  • PSP组快速眼动睡眠行为障碍发生率为33%,低于MSA组的87%和LBD组的90%(p=0.006)。
  • 生前临床诊断准确性:PSP为57%,α-突触核蛋白病为83%。

临床怎么用

  • 在非典型帕金森综合征的鉴别中,缺乏直立性低血压和肾上腺素能功能保留支持PSP而非α-突触核蛋白病。

局限性

  • 本文为回顾性研究,样本量较小(PSP 14例、MSA 18例、LBD 24例),结论需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the pattern and severity of autonomic dysfunction in autopsy-confirmed progressive supranuclear palsy (PSP) compared to α-synuclein pathology. METHODS: Autopsy-confirmed cases of 14 patients with PSP, 18 with multiple system atrophy (MSA), and 24 with Lewy body disease (LBD) with antemortem autonomic testing were reviewed retrospectively. All patients underwent comprehensive clinical evaluations by a movement disorder specialist, formal autonomic testing, and postmortem examinations at Mayo Clinic. RESULTS: The absence of orthostatic hypotension (OH) was the strongest autonomic parameter that distinguished PSP from α-synucleinopathies (0% vs 69%, p < 0.0001). Tests of adrenergic failure, which distinguish neurogenic OH, also differentiated PSP from other groups. These included the pressure recovery time (p = 0.0008), adrenergic impairment score (p = 0.001), and magnitude of change of systolic (p = 0.0002) and diastolic (p = 0.0001) blood pressures (BPs) during upright tilt. In addition, REM sleep behavior disorder was seen less frequently (p = 0.006) in PSP (33%) compared to MSA (87%) and LBD (90%). Antemortem clinical diagnostic accuracy for these phenotypically variable disorders was 57% for PSP and 83% for α-synucleinopathies. CONCLUSION: Our results suggest that the cardiovascular adrenergic system, which sustains BP during standing, is relatively unaffected, if not spared, in PSP. These findings increase our understanding of the clinical signature of PSP and have the potential to improve diagnostic accuracy in atypical parkinsonisms by distinguishing PSP from the α-synucleinopathies.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. van Gerpen JA, Al-Shaikh RH, Tipton PW, et al. Progressive supranuclear palsy is not associated with neurogenic orthostatic hypotension. Neurology. 2019. PMID: 31484717. doi:10.1212/WNL.0000000000008197

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。